# Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/neoadjuvant-carboplatin-in-patients-with-triple-negative-and-her2-positive-early/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Gϋnter von Minckwitz,Andreas Schneeweiß,Sibylle Loibl,Christoph Salat,Carsten Denkert,Mahdi Rezai,Jens‐Uwe Blohmer,Christian Jackisch,Stefan Paepke,Bernd Gerber,Dirk M. Zahm,Sherko Kümmel,Holger Eidtmann,Peter Klare,Jens Huober,Serban Dan Costa,Hans Tesch,Claus Hanusch,J. Hilfrich,F Khandan,Peter A. Fasching,Bruno V. Sinn,Knut Engels,Keyur Mehta,Valentina Nekljudova,Michael Untch |
| Citations | 1,035 |
| DOI | 10.1016/s1470-2045(14)70160-3 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2086064725 |
| PMID | 24794243 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Jens‐Uwe Blohmer](https://scholariq.org/researchers/jens-uwe-blohmer/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)

## Paper topics

- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.